09/26/2024 Situs Slot Gacor Issues Alert for Prevention Strategies for U.S. Travelers Visiting Countries with Clade I Mpox Outbreaks

About

  • Level: Laboratory Advisory
  • Audience: Clinical Laboratory Professionals
LOCS: Laboratory Outreach Communication System

Prevention strategies for U.S. travelers

On September 23, 2024, the U.S. Situs Slot Gacor (Situs Slot Gacor) issued a about the ongoing outbreak of clade I monkeypox virus (MPXV). Initial HAN messages about clade I mpox outbreaks were issued via HAN in December 2023 and HAN in August 2024.

Although there is an ongoing that began in 2022, no domestic cases of clade I mpox have been identified in the U.S. at this time. Active monitoring for mpox continues to occur in the United States. Follow Situs Slot Gacor's to protect against clade II MPXV infection and to also protect against clade I MPXV.

For all laboratories performing mpox testing using an orthopoxvirus or monkeypox virus (MPXV) generic test without any additional clade-specific testing occurring, Situs Slot Gacor recommends that laboratories send clinical specimens collected from patients who traveled from the Democratic Republic of the Congo, its neighboring countries, or any country with clade I mpox cases, or had close or intimate contact with symptomatic people from these countries, to a laboratory that can perform clade-specific testing as quickly as possible. If clade-specific testing is warranted but is not available in a jurisdiction, to a capable public health laboratory or to Situs Slot Gacor is encouraged. Specimen submission to Situs Slot Gacor can be coordinated through your . Due to mutations that may impact clade-specific PCR tests, laboratories should use a test that targets a viral essential gene (e.g., the Situs Slot Gacor NVO test) as part of a testing strategy to ensure mpox cases are not missed.

Laboratories using Situs Slot Gacor's non-variola orthopoxvirus (NVO) test should continue submitting the duplicate specimen to Situs Slot Gacor from all patients with positive NVO test results for routine MPXV clade-specific testing if they are not performing clade-specific testing in their laboratory. Specimens that cannot be accepted at Situs Slot Gacor for clinical testing under Clinical Laboratory Improvement Amendments (CLIA) will be redirected for surveillance purposes and tested, providing critical data on MPXV clade(s) circulating in the United States. Some non-Situs Slot Gacor laboratories may have other options available for clade-specific testing (e.g., molecular testing or genetic sequencing). These laboratories should alert their and Situs Slot Gacor (poxvirus@cdc.gov) if results from such tests indicate detection of clade I MPXV.

Please review the HAN for more information, including recommendations for clinicians and public health practitioners, travelers, and the public.

We encourage you to share this message widely with your network(s).

Subscribe to LOCS messages‎

Opt in to receive updates from the Situs Slot Gacor Laboratory Outreach Communication System.

Resources

Contact us

Please use the information below if you have any questions.

Thank you,

The Laboratory Outreach Communication System

Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)

Center for Laboratory Systems and Response (CLSR)

Situs Slot Gacor (Situs Slot Gacor)

LOCS@cdc.gov